http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105566138-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21c26629760d4cc6ae0ca44ce8315dd5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-44
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C269-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-1514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C25-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J27-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-04
filingDate 2014-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_004284197da6644f8b175ab71cd214ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c5af3d1f23d7ecd5533f7e20bad7cd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33af36fcd4cf4052334860d33e7f90db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d8537bdf44b2d19270b18377ce8227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54e18dfd559b611194ec3882e8aa504f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_103bd63a8d5ac72f900bad022fa8b9cd
publicationDate 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105566138-A
titleOfInvention A kind of method of synthesizing sitagliptin intermediate
abstract The invention relates to a method for synthesizing a sitagliptin intermediate. In the method, formula II is asymmetrically reductively aminated in a suitable organic solvent to obtain formula I with ammonia or ammonium salt in the presence of a chiral phosphorus-coordinated transition metal catalyst and an acidic additive. The R- or S-configuration of the stereocenter is represented by *, and the I of the R configuration can be used to prepare sitagliptin. The reaction formula is: Wherein R and R are each independently selected from hydrogen , C1 -C12 straight or branched chain alkyl, C3-C12 cycloalkyl, C2-C12 alkenyl, C2-C12 alkynyl, C7-C12 aryl alkane base. The method has high yield and ee% value, mild reaction conditions, simple operation, convenient purification, low production cost, environmental friendliness and suitability for industrialized production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106892832-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115894310-A
priorityDate 2014-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100301982
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397492
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466906463
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45031
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25253
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13482

Total number of triples: 39.